Literature DB >> 15881261

The effect of contrast reduction on pattern-reversal VEPs in suspected multiple sclerosis and optic neuritis.

Adrian W Davidson1, Richard F Scott, Keith W Mitchell.   

Abstract

A retrospective study was conducted to investigate whether the use of low-contrast stimuli in addition to the standard high-contrast stimuli would increase the sensitivity of the pattern-reversal P100 when testing for multiple sclerosis (MS) and optic neuritis (ON). We found that there was a statistically significant increase in the number of abnormal results when using 25' checks, but not for 50' checks. Examination of patient records showed that VEP abnormalities to low-contrast stimuli only was not prognostic for subsequent development of multiple sclerosis.

Entities:  

Mesh:

Year:  2004        PMID: 15881261     DOI: 10.1007/s10633-004-3831-9

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  10 in total

Review 1.  Practice parameter: the usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  G S Gronseth; E J Ashman
Journal:  Neurology       Date:  2000-05-09       Impact factor: 9.910

2.  Visual evoked potentials standard (2004).

Authors:  J Vernon Odom; Michael Bach; Colin Barber; Mitchell Brigell; Michael F Marmor; Alma Patrizia Tormene; Graham E Holder
Journal:  Doc Ophthalmol       Date:  2004-03       Impact factor: 2.379

3.  Delayed visual evoked response in optic neuritis.

Authors:  A M Halliday; W I McDonald; J Mushin
Journal:  Lancet       Date:  1972-05-06       Impact factor: 79.321

4.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

5.  Evoked potentials in suspected multiple sclerosis: diagnostic value and prediction of clinical course.

Authors:  A L Hume; S G Waxman
Journal:  J Neurol Sci       Date:  1988-02       Impact factor: 3.181

6.  Guideline nine: guidelines on evoked potentials. American Electroencephalographic Society.

Authors: 
Journal:  J Clin Neurophysiol       Date:  1994-01       Impact factor: 2.177

7.  Evoked potentials in the diagnosis of multiple sclerosis: a follow up study.

Authors:  W B Matthews; J R Wattam-Bell; E Pountney
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-04       Impact factor: 10.154

8.  Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: a prospective 2-year follow-up with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT.

Authors:  K H Lee; S A Hashimoto; J P Hooge; L F Kastrukoff; J J Oger; D K Li; D W Paty
Journal:  Neurology       Date:  1991-05       Impact factor: 9.910

9.  Sensitivities and predictive values of paraclinical tests for diagnosing multiple sclerosis.

Authors:  G Filippini; G C Comi; V Cosi; L Bevilacqua; M Ferrarini; V Martinelli; R Bergamaschi; M Filippi; A Citterio; L D'Incerti
Journal:  J Neurol       Date:  1994-01       Impact factor: 4.849

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

  10 in total
  2 in total

1.  Evaluation of optic neuropathy in multiple sclerosis using low-contrast visual evoked potentials.

Authors:  M J Thurtell; E Bala; S S Yaniglos; J C Rucker; N S Peachey; R J Leigh
Journal:  Neurology       Date:  2009-12-01       Impact factor: 9.910

2.  Pattern visual evoked potentials in Japanese patients with multiple sclerosis without history of visual pathway involvement.

Authors:  Atsushi Mizota; Noriko Asaumi; Michihiko Takasoh; Emiko Adachi-Usami
Journal:  Doc Ophthalmol       Date:  2007-06-05       Impact factor: 2.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.